Accès libre

The Importance of Positive Immunomagnetic Cell Separation Prior to Autologous Hematopoetic Stem Cell Transplantation for Advanced Stage Lymphomas

À propos de cet article

Citez

1. Vonk AL, de Windt TS, Slaper-Cortenbach ICM, Saris DBF. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy. Stem Cell Res Ther. 2015;6:94.10.1186/s13287-015-0086-1443090425976213Search in Google Scholar

2. Kimbrel EA, Kouris NA, Yavanian GJ, et al. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev. 2014;23:1611-1624.10.1089/scd.2013.0554408636224650034Search in Google Scholar

3. Isolex 300i Trening Manual, Version 2, Nexel Therapeutics Inc. USA, 2001, Section 2Search in Google Scholar

4. McDonald-Hyman C, Turka LA, Blazar BR. Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med. 2015;7:280rv2.10.1126/scitranslmed.aaa6853442535425810312Search in Google Scholar

5. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasm. Blood. 2008;111:3941-3967.10.1182/blood-2007-11-12053518198345Search in Google Scholar

6. Padmanee Sharma, James P. Allison, Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential. Cell Press. 2015;161:205-214.Search in Google Scholar

7. Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro. Stem Cells Dev. 2015;24:1635-1647.10.1089/scd.2014.0316449979025867197Search in Google Scholar

8. Bernardo ME, Fibbe WE. Mesenchymal stromal cells and hematopoietic stem cell transplantation, facilitate engraftment to treat steroid resistant acute graft-versus-host disease, Immunol Lett. 2015;168:215-221.Search in Google Scholar

9. Cruz CR, Bollard CM. T-Cell and Natural Killer Cell Therapies For Hematologic Malignancies After Hematopoietic Stem Cell Transplantation: Enhancing The Graft-Versus-Leukemia Effect. Haematologica. 2015;100:709-719.10.3324/haematol.2014.113860445061626034113Search in Google Scholar

10. De Becker A, Van Riet I. Mesenchymal Stromal Cell Therapy in Hematology: From Laboratory to Clinic and Back Again. Stem Cells Dev. 2015;24:1713-1729.10.1089/scd.2014.056425923433Search in Google Scholar

11. Lendvai N, Cohen AD, Cho HJ. Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma. Bone Marrow Transplant. 2015;50:770-780.10.1038/bmt.2015.525751647Search in Google Scholar

12. Apperley J, Carreras E, Gluckman E, Gratwohl A, Massi T. The EBMT Handbook, 5th Edition: Haematopoietic Stem Cell Transplantation. Revised Edition; 2008.Search in Google Scholar

eISSN:
2501-8132
Langue:
Anglais